Breakthrough in HIV/AIDS Research: Novel Approach Targets Drug-Resistant Strains

Researchers from Colorado State University have made a significant breakthrough in HIV/AIDS research by developing a novel approach to combat drug-resistant strains of the disease. According to a new study published in Scientific Reports, the team designed a high-throughput screening platform that targets the precursor autoprocessing of the HIV-1 protease, a key enzyme involved in the replication of the virus. This innovative approach identified 27 compounds that partially suppressed precursor autoprocessing, with several compounds exhibiting strong antiviral activity against both wild-type and drug-resistant HIV strains.

Key Takeaways:

• The study developed a high-throughput screening platform targeting precursor autoprocessing of HIV-1 protease, a novel approach to combat drug-resistant strains.
• Researchers screened approximately 320,000 small molecules and identified 27 compounds that partially suppressed precursor autoprocessing.
• Several compounds exhibited strong antiviral activity against both wild-type and drug-resistant HIV strains, with EC values in the low micromolar range.
• The study suggests that antiviral activity is influenced by specific chemical groups, providing a basis for further optimization of the compounds.
• Notably, hit compound C7 exhibited comparable potency against both wild-type and drug-resistant HIV strains, hinting at a novel mechanism of action.
• The study provides proof of concept for an innovative drug discovery approach targeting HIV-1 PR autoprocessing as a potential strategy to combat drug resistance.

Statistics:

• Approximately 320,000 small molecules were screened in the high-throughput screening platform.
• 27 compounds were identified that partially suppressed precursor autoprocessing.
• Several compounds exhibited strong antiviral activity against both wild-type and drug-resistant HIV strains, with EC values in the low micromolar range (e.g., 0.1-1 μM).
• The study suggests that antiviral activity is influenced by specific chemical groups.

Sources:

• High-throughput screening and characterization of novel inhibitors targeting HIV-1 protease precursor autoprocessing. Scientific Reports, 2025;15(1):35287.
• NewsRx. Studies from Colorado State University Reveal New Findings on HIV/AIDS (High-throughput screening and characterization of novel inhibitors targeting HIV-1 protease precursor autoprocessing). AIDS Weekly. October 20, 2025; p 211.